Showing results (1-10 of 136) with videos related to
Sort By:
Pageof 14
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1981
The dual interaction of prostaglandin E2 (PGE2) and interferon (IFN) on NK lytic activation: enhanced capacity of effector-target lytic interactions (recycling) and blockage of pre-NK cell recruitmentS R TarganCanadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|October 7, 2000
Biology of inflammation in Crohn's disease: mechanisms of action of anti-TNF-a therapyS R TarganJournal of Immunology (Baltimore, Md. : 1950)|September 1, 1983
Definition of a "trigger" stage in the NK cytolytic reaction sequence by a monoclonal antibody to the glycoprotein T-200S R Targan, W NewmanJournal of Immunology (Baltimore, Md. : 1950)|March 1, 1983
Identification of human natural killer soluble cytotoxic factors (NKCF) derived from NK-enriched lymphocyte populations: specificity of generation and killingE Farram, S R TarganJournal of Immunology (Baltimore, Md. : 1950)|June 1, 1983
The "lazy" NK cells of Chediak-Higashi syndromeS R Targan, R OseasGastroenterology Clinics of North America|June 18, 1999
Current theories on the causes of inflammatory bowel diseaseK A Papadakis, S R TarganDigestive Diseases and Sciences|September 1, 1994
Immunomodulator therapy in inflammatory bowel diseaseP M Choi, S R TarganJournal of Immunology (Baltimore, Md. : 1950)|July 1, 1984
Evidence of a dynamic role of the target cell membrane during the early stages of the natural killer cell lethal hitR L Deem, S R TarganJournal of Immunology (Baltimore, Md. : 1950)|October 1, 1984
Sequential substages of natural killer cell-derived cytolytic factor (NKCF)-mediated cytolysis as defined by glutaraldehyde modulation of the target cellR L Deem, S R TarganCurrent Gastroenterology Reports|September 12, 2000
Serologic testing in inflammatory bowel disease: its value in indeterminate colitisK A Papadakis, S R TarganPageof 14